← Back to Search

Local Anesthetic

1 for Pain (Epidural Trial)

N/A
Waitlist Available
Led By Michael Haydon, MD
Research Sponsored by MemorialCare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Early labor Nulliparous
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of labor
Awards & highlights

Epidural Trial Summary

The investigators intend to perform a large randomized trial using standardized obstetrical and anesthetic practice at a single institution to determine the effects of patient controlled epidural analgesia on obstetrical and neonatal outcomes.

Epidural Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Epidural Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of labor
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of labor for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total bupivicaine used
Secondary outcome measures
maternal satisfaction

Epidural Trial Design

3Treatment groups
Experimental Treatment
Group I: 3Experimental Treatment1 Intervention
patient controlled anesthesia only this arm has pt controlled medication delivery. (PCA)
Group II: 2Experimental Treatment1 Intervention
continuous epidural infusion in conjuction with patient controlled anesthesia (PCA)
Group III: 1Experimental Treatment1 Intervention
Continuous epidural infusion of medication for method of pain relief
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved

Find a Location

Who is running the clinical trial?

MemorialCareLead Sponsor
7 Previous Clinical Trials
789 Total Patients Enrolled
Michael Haydon, MDPrincipal InvestigatorMemorial care Health Sytem Physcian

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025